Rus Eng
Main / Company's news / CEO of GEROPHARM at the working session organized by the Minister of Industry and Trade of the Russian Federation in the special economic zone "Neudorf"

CEO of GEROPHARM at the working session organized by the Minister of Industry and Trade of the Russian Federation in the special economic zone "Neudorf"

29 April 2011

On April 26th a working session took place within the scope of St. Petersburg International Forum on pharmaceutics and biotechnologies; the session was headed by the Minister of Industry and Trade of Russian Federation V. Khristenko. The representatives of public authorities and businesses met to discuss the current issues of pharmaceutical cluster development: vice-governor of St. Petersburg - M. Oseevskiy, chairman of the Committee for Economic Development, Industrial Policy and Trade - E. Yelin, deputy chairman of the Committee for Economic Development, Industrial Policy and Trade - Z. Golant, as well as the heads of the leading pharmaceutical companies – among them the participants of St. Petersburg pharmaceutical cluster.

SEZ "Neudorf" was specially chosen as the session site: in July 2010 in SEZ “Neudorf” hosted a gala-opening of the business center, the Minister of Economic Development of the Russian Federation, E. Nabiullina, among the participants. On the whole, 2010 was a year full of important strategic decisions determining the development of the pharmaceutical cluster of St. Petersburg in many ways: the concept of a cluster was approved, a special industrial zone Pushkinskaya and a special economic zone “Neudorf” were formed as a platform for scientific research. At the opening ceremony of the center the SEZ residents presented some R&D plans, and almost a year later the participants of the session summarized the first intermediate results of their work, and also discussed the prospects of the innovative development of the pharmaceutical industry.

One of the first R&D projects to be implemented in the SEZ "Neudorf" was a project by GEROPHARM to create a research center of the international level. Peter Rodionov, the CEO of GEROPHARM, emphasized that the project, focused on the development of new drugs, will contribute to the realization of the Federal Strategy PHARMA-2020. The company plans to work on generic drugs which are a priority in terms of import substitution and on some innovative drugs which will be used for treating the socially significant diseases. The research will be mainly focused on the synthesis of original substances, the development of the innovative peptide and genetically engineered drugs, as well as the diagnostic systems having no equivalents in the world, and will help to diagnose the diseases at an early stage and monitor the effectiveness of the therapy.

The long-term strategy of GEROPHARM provides the complex development: apart from the R&D center, the company is implementing a project of building a modern industrial complex that will be located in the pharmaceutical cluster in the Puskinskaya industrial zone. The pharmaceutical development, that is a complex of events focused on the development, analysis and the introduction of new drugs to be implemented in the research center of the company in SEZ “Neudorf”, will help to speed up the process of the adoption of laboratory products in the industrial production, and also to minimize the technical difficulties of this transitional stage.

You are a health care professional?

Go up